Chroma Medication Secures $135M in Sequence B Financing to Advance Breakthrough Epigenetic Modifying Know-how and Broaden Pipeline of Sturdy Precision Genomic
Funding to progress Chroma’s single-dose epigenetic modifying therapies and help growth of novel genetic drugs platform designed to allow exact…